Sonnet BioTherapeutics
SONN
SONN
21 hedge funds and large institutions have $2.11M invested in Sonnet BioTherapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.02M | |
| 2 | +$136K | |
| 3 | +$68.9K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$46.3K |
| 5 |
VF
Virtu Financial
New York
|
+$42K |
Top Sellers
| 1 | -$634K | |
| 2 | -$599K | |
| 3 | -$343K | |
| 4 |
AC
Ayrton Capital
Westport,
Connecticut
|
-$276K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$253K |